Balchandra Awale Rupali, Ghatak Tanmoy, Samanta Sukhen, Singh Ratender K, Verma Anupam, Mishra Prabhakar, Chaudhary Rajendra, Nath Alok
Department of Laboratory Medicine, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
Department of Emergency Medicine, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
Anesth Essays Res. 2022 Jan-Mar;16(1):65-70. doi: 10.4103/aer.aer_52_22. Epub 2022 Jun 27.
Knowledge of underlying pathophysiology of coagulopathy is evolving and the pattern of coagulation parameters in coronavirus disease 2019 (COVID-19)-associated diseases is still not very clear.
In the present study, we aimed to find out the pattern and distribution of conventional coagulation parameters and thromboelastographic (TEG) parameters in COVID-19-associated coagulopathy (CAC) in survivors and nonsurvivors at 28 days.
The present prospective observational study was conducted at a tertiary care COVID-19 intensive care unit (ICU) facility from March 21, 2020, to July 15, 2021.
Admission clinical and laboratory data (conventional coagulation, inflammatory and TEG parameters, and disease severity parameters) of 64 COVID-19 patients admitted to the ICU were collected. Patients were divided into two groups, i.e., survivors and nonsurvivors.
Data were compared between two groups, i.e., survivors versus no survivors on 28 days using Student's -test/Mann-Whitney U-test or Chi-square test/Fisher's exact test.
Admission mean plasma fibrinogen levels (474.82 ± 167.41 mg.dL) and D-dimer were elevated (1.78 [0.66, 3.62] mg.mL) in the COVID-19 ICU patients. Overall, COVID-19 patients had mean lower normal platelet count (150 ± 50 × 10 cells.mm), with marginally elevated prothrombin time (16.25 ± 3.76 s) and activated partial thromboplastin time (38.22 ± 16.72 s). A 65.6% (42/64) TEG profile analysis showed a normal coagulation profile, and the rest 21.9% (14/64) and 12.5% (8/64) had hypercoagulable and hypocoagulable states, respectively. Plasma D-dimer level was markedly elevated in nonsurvivors compared to survivors ( < 0.05), while no other conventional coagulation parameters and TEG profile demonstrated statistically significant between the two groups.
Markedly elevated plasma D-dimer level was observed in nonsurvivors of COVID-19 ICU patients. A large portion of COVID-19 ICU patients had a normal TEG profile. Conventional coagulation parameters and TEG profile were similar between survivors and nonsurvivors.
凝血病潜在病理生理学的知识正在不断发展,2019冠状病毒病(COVID-19)相关疾病中凝血参数的模式仍不太清楚。
在本研究中,我们旨在找出28天时COVID-19相关凝血病(CAC)幸存者和非幸存者中传统凝血参数和血栓弹力图(TEG)参数的模式及分布情况。
本前瞻性观察性研究于2020年3月21日至2021年7月15日在一家三级医疗COVID-19重症监护病房(ICU)进行。
收集了64例入住ICU的COVID-19患者的入院临床和实验室数据(传统凝血、炎症和TEG参数以及疾病严重程度参数)。患者分为两组,即幸存者和非幸存者。
使用学生t检验/曼-惠特尼U检验或卡方检验/费舍尔精确检验,比较两组(即28天时的幸存者与非幸存者)的数据。
COVID-19 ICU患者入院时血浆纤维蛋白原平均水平(474.82±167.41mg/dL)和D-二聚体升高(1.78[0.66,3.62]mg/mL)。总体而言,COVID-19患者血小板计数均值略低于正常(150±50×10⁹个细胞/mm³),凝血酶原时间(16.25±3.76秒)和活化部分凝血活酶时间(38.22±16.72秒)略有升高。65.6%(42/64)的TEG分析显示凝血模式正常,其余21.9%(14/64)和12.5%(8/64)分别处于高凝和低凝状态。与幸存者相比,非幸存者的血浆D-二聚体水平显著升高(P<0.05),而两组之间其他传统凝血参数和TEG模式均无统计学显著差异。
在COVID-19 ICU患者的非幸存者中观察到血浆D-二聚体水平显著升高。大部分COVID-19 ICU患者的TEG模式正常。幸存者和非幸存者之间的传统凝血参数和TEG模式相似。